There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acer Therapeutics (ACER) and BioNano Genomics (BNGO) with bullish sentiments.
Acer Therapeutics (ACER)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Acer Therapeutics today and set a price target of $10.00. The company’s shares closed last Thursday at $2.66.
According to TipRanks.com, Selvaraju is a 5-star analyst with an average return of 18.1% and a 54.1% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Biospecifics Technologies, Springworks Therapeutics, and Protalix Biotherapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Acer Therapeutics with a $10.00 average price target.
See today’s analyst top recommended stocks >>
BioNano Genomics (BNGO)
In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on BioNano Genomics, with a price target of $1.50. The company’s shares closed last Thursday at $0.57.
According to TipRanks.com, DeGeeter is a 5-star analyst with an average return of 29.6% and a 51.7% success rate. DeGeeter covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, Rocket Pharmaceuticals, and Ionis Pharmaceuticals.
Currently, the analyst consensus on BioNano Genomics is a Strong Buy with an average price target of $1.55.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
